11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome
Open accessThe DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Abstract
Context: Androgen excess is a defining feature of polycystic ovary syndrome (PCOS), but the exact origin of hyperandrogenemia remains a matter of debate. Recent studies have highlighted the importance of the 11-oxygenated C19 steroid pathway to androgen metabolism in humans. In this study, we analyzed the contribution of 11-oxygenated androgens to androgen excess in women with PCOS. Methods: One hundred fourteen women with PCOS and 49 healthy control subjects underwent measurement of serum androgens by liquid chromatography-tandem mass spectrometry. Twenty-four–hour urinary androgen excretion was analyzed by gas chromatography-mass spectrometry. Fasting plasma insulin and glucose were measured for homeostatic model assessment of insulin resistance. Baseline demographic data, including body mass index, were recorded. Results: As expected, serum concentrations of the classic androgens testosterone (P < 0.001), androstenedione (P < 0.001), and dehydroepiandrosterone (P < 0.01) were significantly increased in PCOS. Mirroring this, serum 11-oxygenated androgens 11β-hydroxyandrostenedione, 11-ketoandrostenedione, 11β-hydroxytestosterone, and 11-ketotestosterone were significantly higher in PCOS than in control subjects, as was the urinary 11-oxygenated androgen metabolite 11β-hydroxyandrosterone. The proportionate contribution of 11-oxygenated to total serum androgens was significantly higher in patients with PCOS compared with control subjects [53.0% (interquartile range, 48.7 to 60.3) vs 44.0% (interquartile range, 32.9 to 54.9); P < 0.0001]. Obese (n = 51) and nonobese (n = 63) patients with PCOS had significantly increased 11-oxygenated androgens. Serum 11β-hydroxyandrostenedione and 11-ketoandrostenedione correlated significantly with markers of insulin resistance. Conclusions: We show that 11-oxygenated androgens represent the majority of circulating androgens in women with PCOS, with close correlation to markers of metabolic risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“11KA4 is the next most abundant 11-oxygenated androgen precursor in circulation (Table 2) [39,41,68,69,289].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [41]
The cited source says what the claim attributes to it.
In the citing paper
“While the levels of 11-oxygenated androgens and their precursors have been shown to be significantly elevated in patients with polycystic ovary syndrome (PCOS) and 21-hydroxylase deficiency [41,69], one study reported that the circulating levels of 11KT were also higher than that of testosterone in a healthy female control group (BMI 21.2–26.1 kg/m2) [41].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [41]
The cited source says what the claim attributes to it.
In the citing paper
“The significant levels of 11KA4 measured in the serum of healthy premenopausal woman (O'Reilly et al., 2016) supports the involvement of peripheral tissue such as the kidney, especially considering that the adrenal expresses only low levels of HSD11B2 (Coulter et al., 1999).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as O'Reilly et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“Notably, the androgen profile in endometriosis, as described in our study, is different from that reported for PCOS.13”
From Steroid hormone profiling reveals altered adrenal androgen production in endometriosis (2026) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“In PCOS, median concentrations of 11OHA4, and 11KA4, as reported by O’Reilly et al., are 31.7 nmol/L and 13.4 nmol/L, respectively, and are increased relative to healthy controls.”
From Steroid hormone profiling reveals altered adrenal androgen production in endometriosis (2026) · cites this paper as [13]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0253 · Cited by 676
Arlt, W., Walker, E. A., Draper, N., Ivison, H. E., Ride, J. P., Hammer, F., Chalder, S. M., Borucka-Mankiewicz, M., Hauffa, B. P., Malunowicz, E. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16503-3 · Cited by 345
Self-citationO'Reilly, M. W., Taylor, A. E., Crabtree, N. J., Hughes, B. A., Capper, F., Crowley, R. K., Stewart, P. M., Tomlinson, J. W., & Arlt, W. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3399 · Cited by 283
Self-citationTurcu, A. F., Nanba, A. T., Chomic, R., Upadhyay, S. K., Giordano, T. J., Shields, J. J., Merke, D. P., Rainey, W. E., & Auchus, R. J. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1181 · Cited by 231
Rege, J., Nakamura, Y., Satoh, F., Morimoto, R., Kennedy, M. R., Layman, L. C., Honma, S., Sasano, H., & Rainey, W. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2912 · Cited by 227
Storbeck, K.-H., Bloem, L. M., Africander, D., Schloms, L., Swart, P., & Swart, A. C. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.07.006 · Cited by 198
Self-citationQuinkler, M., Sinha, B., Tomlinson, J. W., Bujalska, I. J., Stewart, P. M., & Arlt, W. (2004) · Journal of Endocrinology · doi:10.1677/joe.1.05762 · Cited by 190
Self-citation
Cited by
Witchel, S. F., Oberfield, S. E., & Peña, A. S. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00078 · Cited by 653
Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance
Handelsman, D. J., Hirschberg, A. L., & Bermon, S. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00020 · Cited by 594
Polycystic Ovarian Syndrome: Correlation Between Hyperandrogenism, Insulin Resistance and Obesity.
Zeng, X., Xie, Y.-J., Liu, Y.-T., Long, S.-L., & Mo, Z.-C. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.11.003 · Cited by 525
Martin, K. A., Chang, R. J., Ehrmann, D. A., Ibanez, L., Lobo, R. A., Rosenfield, R. L., Shapiro, J., Montori, V. M., & Swiglo, B. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2437 · Cited by 512
Ibáñez, L., Oberfield, S. E., Witchel, S., Auchus, R. J., Chang, R. J., Codner, E., Dabadghao, P., Darendeliler, F., Elbarbary, N. S., Gambineri, A., et al. (2017) · Hormone Research in Paediatrics · doi:10.1159/000479371 · Cited by 463
Schiffer, L., Barnard, L., Baranowski, E. S., Gilligan, L. C., Taylor, A. E., Arlt, W., Shackleton, C. H. L., & Storbeck, K.-H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105439 · Cited by 450
Self-citationMartin, K. A., Anderson, R. R., Chang, R. J., Ehrmann, D. A., Lobo, R. A., Murad, M. H., Pugeat, M. M., & Rosenfield, R. L. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00241 · Cited by 339
Armanini, D., Boscaro, M., Bordin, L., & Sabbadin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084110 · Cited by 324
Xu, Y., & Qiao, J. (2022) · Journal of Healthcare Engineering · doi:10.1155/2022/9240569 · Cited by 283
Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism
Arlt, W., Lang, K., Sitch, A. J., Dietz, A. S., Rhayem, Y., Bancos, I., Feuchtinger, A., Chortis, V., Gilligan, L. C., Ludwig, P., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93136 · Cited by 281
Self-citationAboeldalyl, S., James, C., Seyam, E., Ibrahim, E. M., Shawki, H. E.-D., & Amer, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052734 · Cited by 239
11-Oxygenated androgens in health and disease
Turcu, A. F., Rege, J., Auchus, R. J., & Rainey, W. E. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0336-x · Cited by 217
Intracrine androgen biosynthesis, metabolism and action revisited
Schiffer, L., Arlt, W., & Storbeck, K.-H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.016 · Cited by 217
Self-citationO’Reilly, M. W., Kempegowda, P., Walsh, M., Taylor, A. E., Manolopoulos, K. N., Allwood, J. W., Semple, R. K., Hebenstreit, D., Dunn, W. B., Tomlinson, J. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00947 · Cited by 215
Self-citationInsulin resistance and PCOS: chicken or egg?
Moghetti, P., & Tosi, F. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01351-0 · Cited by 209
Kumarendran, B., O’Reilly, M. W., Manolopoulos, K. N., Toulis, K. A., Gokhale, K. M., Sitch, A. J., Wijeyaratne, C. N., Coomarasamy, A., Arlt, W., & Nirantharakumar, K. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002542 · Cited by 206
Self-citationBasics of androgen synthesis and action
Naamneh Elzenaty, R., du Toit, T., & Flück, C. E. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101665 · Cited by 199
Structural and functional biology of aldo-keto reductase steroid transforming enzymes
Penning, T. M., Wangtrakuldee, P., & Auchus, R. J. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00089 · Cited by 164
Rege, J., Turcu, A., Kasa-Vubu, J. Z., Lerario, A. M., Auchus, G. C., Auchus, R. J., Smith, J. M., White, P. C., & Rainey, W. E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00736 · Cited by 154
MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease
Schiffer, L., Kempegowda, P., Arlt, W., & O’Reilly, M. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0124 · Cited by 171
Self-citationO’Reilly, M., Westgate, C. S. J., Hornby, C., Botfield, H. F., TAYLOR, A. E. R., Markey, K. A., Mitchell, J., Scotton, W. J., Mollan, S. P., Yiangou, A., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.125348 · Cited by 161
Self-citationThe Roles of Androgens in Humans: Biology, Metabolic Regulation and Health
Alemany, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911952 · Cited by 175
Hyperandrogenic origins of polycystic ovary syndrome-Implications for Pathophysiology and Therapy
Abbott, D. H., Dumesic, D. A., & Levine, J. E. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1576522 · Cited by 131
Polycystic Ovary Syndrome: Pathophysiology and Therapeutic Opportunities
Dong, J., & Rees, D. A. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2023-000548 · Cited by 123
Diagnosis of Polycystic Ovary Syndrome
Chang, S., & Dunaif, A. E. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.10.002 · Cited by 189
The diagnosis and treatment of PCOS in adolescents: an update
Witchel, S. F., Burghard, A. C., Tao, R. H., & Oberfield, S. E. (2019) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000778 · Cited by 119
Androgens During the Reproductive Years: What Is Normal for Women?
Skiba, M. A., Bell, R. J., Islam, R. M., Handelsman, D. J., Desai, R., & Davis, S. R. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01357 · Cited by 134
Androgen excess: a hallmark of polycystic ovary syndrome
Wang, K., Lǐ, Y., & Chen, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1273542 · Cited by 156
11-oxygenated C19 steroids Do not decline with age in women
Nanba, A. T., Rege, J., Ren, J., Auchus, R. J., Rainey, W. E., & Turcu, A. F. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02527 · Cited by 113
Microbial Hydroxysteroid Dehydrogenases: From Alpha to Omega
Doden, H. L., & Ridlon, J. M. (2021) · Microorganisms · doi:10.3390/microorganisms9030469 · Cited by 118
Androgens and ovarian function: translation from basic discovery research to clinical impact
Walters, K. A., Rodriguez Paris, V, Aflatounian, A., & Handelsman, D. J. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0096 · Cited by 104
Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study
Subramanian, A., Anand, A., Adderley, N. J., Okoth, K., Toulis, K. A., Gokhale, K. M., Sainsbury, C. A. R., O’Reilly, M., Arlt, W., & Nirantharakumar, K. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1163 · Cited by 104
Self-citationSignaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
Wang, K., & Lǐ, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1191759 · Cited by 127
Approach to androgen excess in women: Clinical and biochemical insights
Cussen, L., McDonnell, T., Bennett, G., Thompson, C. J., Sherlock, M., & O’Reilly, M. (2022) · Clinical Endocrinology · doi:10.1111/cen.14710 · Cited by 110
Self-citationMonogenic disorders of adrenal steroidogenesis
Baranowski, E. S., Arlt, W., & Idkowiak, J. (2018) · Hormone Research in Paediatrics · doi:10.1159/000488034 · Cited by 79
Self-citationClinical significance of 11-oxygenated androgens
Turcu, A. F., & Auchus, R. J. (2017) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000334 · Cited by 80
Causes, Patterns, and Severity of Androgen Excess in 1205 Consecutively Recruited Women
Elhassan, Y. S., Idkowiak, J., Smith, K., Asia, M., Gleeson, H., Webster, R., Arlt, W., & O’Reilly, M. W. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02426 · Cited by 80
Self-citationCurrent concepts of polycystic ovary syndrome pathogenesis
Rosenfield, R. L. (2020) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000945 · Cited by 77
Häkkinen, M. R., Murtola, T., Voutilainen, R., Poutanen, M., Linnanen, T., Koskivuori, J., Lakka, T., Jääskeläinen, J., & Auriola, S. (2019) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.11.035 · Cited by 74
Barnard, M., Quanson, J. L., Mostaghel, E., Pretorius, E., Snoep, J. L., & Storbeck, K.-H. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.06.013 · Cited by 72
Self-citationImplicating androgen excess in propagating metabolic disease in polycystic ovary syndrome
Kempegowda, P., Melson, E., Manolopoulos, K. N., Arlt, W., & O’Reilly, M. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820934319 · Cited by 87
Self-citationCognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure
Grech, O., Clouter, A., Mitchell, J., Alimajstorovic, Z., Ottridge, R. S., Yiangou, A., Roque, M., Tahrani, A. A., Nicholls, M., TAYLOR, A. E. R., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab202 · Cited by 76
Self-citationAlternative pathway androgen biosynthesis and human fetal female virilization
Reisch, N., Taylor, A. E., Nogueira, E. F., Asby, D. J., Dhir, V., Berry, A., Krone, N., Auchus, R. J., Shackleton, C. H. L., Hanley, N. A., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906623116 · Cited by 70
Self-citationCutler, D. A., Pride, S. M., & Cheung, A. P. (2019) · Food Science & Nutrition · doi:10.1002/fsn3.977 · Cited by 69
Abiraterone acetate treatment lowers 11-oxygenated androgens
Wright, C., O’Day, P., Alyamani, M., Sharifi, N., & Auchus, R. J. (2020) · European Journal of Endocrinology · doi:10.1530/eje-19-0905 · Cited by 68
Circulating 11-oxygenated androgens across species
Rege, J., Garber, S., Conley, A. J., Elsey, R. M., Turcu, A. F., Auchus, R. J., & Rainey, W. E. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.04.005 · Cited by 67
The role of adrenal derived androgens in castration resistant prostate cancer
Barnard, M., Mostaghel, E. A., Auchus, R. J., & Storbeck, K. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105506 · Cited by 69
Self-citationLy, L. K., Rowles, J. L., Paul, H. M., Alves, J. M. P., Yemm, C., Wolf, P. M., Devendran, S., Hudson, M. E., Morris, D. J., Erdman, J. W., et al. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105567 · Cited by 71
The clinical and biochemical significance of 11-oxygenated androgens in human health and disease
Storbeck, K.-H., & O’Reilly, M. W. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad047 · Cited by 63
Self-citationAbnormal GnRH pulsatility in polycystic ovary syndrome: Recent insights
McCartney, C. R., & Campbell, R. E. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.04.005 · Cited by 62
Long‐term health outcomes in young women with polycystic ovary syndrome: A narrative review
Allen, L. A., Shrikrishnapalasuriyar, N., & Rees, A. (2021) · Clinical Endocrinology · doi:10.1111/cen.14609 · Cited by 80
Paulukinas, R. D., Mesaros, C., & Penning, T. M. (2022) · Endocrinology · doi:10.1210/endocr/bqac068 · Cited by 69
Glucocorticoid Sexual Dimorphism in Metabolism: Dissecting the Role of Sex Hormones
Kroon, J., Pereira, A. M., & Meijer, O. C. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.01.010 · Cited by 71
Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman
Hirschberg, A. L. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac673 · Cited by 73
Association of Androgen Excess with Glucose Intolerance in Women with Polycystic Ovary Syndrome
Zhang, B., Wang, J., Shen, S., Liu, J., Sun, J., Gu, T., Ye, X., Zhu, D., & Bi, Y. (2018) · BioMed Research International · doi:10.1155/2018/6869705 · Cited by 73
Hardy, R., Botfield, H. F., Markey, K. A., Mitchell, J., Alimajstorovic, Z., Westgate, C. S. J., Sagmeister, M. S., Fairclough, R. J., Ottridge, R. S., Yiangou, A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa766 · Cited by 58
Self-citation11-oxygenated C19 steroids as circulating androgens in women with polycystic ovary syndrome
Yoshida, T., Matsuzaki, T., Miyado, M., Saito, K., Iwasa, T., Matsubara, Y., Ogata, T., Irahara, M., & Fukami, M. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej18-0212 · Cited by 59
Tan, S., Ignatenko, S., Wagner, F. D., Dokras, A., Seufert, J., Zwanziger, D., Dunschen, K., Zakaria, M., Huseinovic, N., Basson, C. T., et al. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14495 · Cited by 62
Inflammatory perspectives of polycystic ovary syndrome: role of specific mediators and markers
Dey, R., Bhattacharya, K., Basak, A. K., Paul, N., Bandyopadhyay, R., Chaudhuri, G. R., Purkait, M. P., Bhattacharjee, A., Bose, C., Shukla, N., et al. (2023) · Middle East Fertility Society Journal · doi:10.1186/s43043-023-00158-2 · Cited by 69
Multi-steroid profiling by UHPLC-MS/MS with post-column infusion of ammonium fluoride
Schiffer, L., Shaheen, F., Gilligan, L. C., Storbeck, K.-H., Hawley, J. M., Keevil, B. G., Arlt, W., & Taylor, A. E. (2022) · Journal of Chromatography B · doi:10.1016/j.jchromb.2022.123413 · Cited by 52
Self-citationThe Rise, Fall, and Resurrection of 11-Oxygenated Androgens in Human Physiology and Disease
Turcu, A. F., Nanba, A. T., & Auchus, R. J. (2018) · Hormone Research in Paediatrics · doi:10.1159/000486036 · Cited by 60
Dehydroepiandrosterone enhances decidualization in women of advanced reproductive age
Gibson, D. A., Simitsidellis, I., Kelepouri, O., Critchley, H. O. D., & Saunders, P. T. K. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.12.024 · Cited by 51
New perspectives on the definition and management of polycystic ovary syndrome
Pasquali, R., & Gambineri, A. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0832-1 · Cited by 59
Storbeck, K.-H., Gilligan, L., Jenkinson, C., Baranowski, E. S., Quanson, J. L., Arlt, W., & Taylor, A. E. (2018) · Journal of Chromatography B · doi:10.1016/j.jchromb.2018.03.033 · Cited by 49
Self-citationMukherjee, A. G., Wanjari, U. R., Kannampuzha, S., Murali, R., Namachivayam, A., Ganesan, R., Dey, A., Babu, A., Renu, K., Vellingiri, B., et al. (2023) · Metabolites · doi:10.3390/metabo13010129 · Cited by 64
Handelsman, D. J., Gibson, E., Davis, S. R., Golebiowski, B., Walters, K. A., & Desai, R. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa086 · Cited by 53
Nonclassic Congenital Adrenal Hyperplasia
Jha, S., & Turcu, A. F. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.10.008 · Cited by 64
Carmina, E., Stanczyk, F. Z., & Løbo, R. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00034-2 · Cited by 59
Contemporary approaches to the management of polycystic ovary syndrome
Pasquali, R. (2018) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018818756790 · Cited by 63
Steroid biomarkers in human adrenal disease
Rege, J., Turcu, A. F., Else, T., Auchus, R. J., & Rainey, W. E. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.01.018 · Cited by 52
Dhayat, N. A., Marti, N., Kollmann, Z., Troendle, A., Bally, L., Escher, G., Grössl, M., Ackermann, D., Ponte, B., Pruijm, M., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0203903 · Cited by 43
Bacila, I., Adaway, J., Hawley, J., Mahdi, S., Krone, R., Patel, L., Alvi, S., Randell, T., Gevers, E., Dattani, M., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00031 · Cited by 44
Schiffer, L., Kempegowda, P., Sitch, A. J., Adaway, J. E., Shaheen, F., Ebbehoj, A., Singh, S., McTaggart, M. P., O’Reilly, M. W., Prete, A., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvac017 · Cited by 42
Self-citationGent, R., du Toit, T., Bloem, L. M., & Swart, A. C. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.02.013 · Cited by 42
Androgen signalling in the ovaries and endometrium
Lissaman, A. C., Girling, J. E., Cree, L. M., Campbell, R. E., & Ponnampalam, A. P. (2023) · Molecular Human Reproduction · doi:10.1093/molehr/gaad017 · Cited by 45
Jha, S., Turcu, A. F., Sinaii, N., Brookner, B., Auchus, R. J., & Merke, D. P. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa192 · Cited by 39
The P450 side-chain cleavage enzyme Cyp11a2 facilitates steroidogenesis in zebrafish
Li, N., Oakes, J., Storbeck, K., Cunliffe, V. T., & Krone, N. P. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0384 · Cited by 38
Self-citationSteroid metabolism in breast cancer: Where are we and what are we missing?
Africander, D., & Storbeck, K. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.05.016 · Cited by 44
Self-citationAdrenal androgens, adrenarche, and zona reticularis: A human affair?
Dumontet, T., & Martinez, A. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111239 · Cited by 44
An expanded metabolic pathway for androgen production by commensal bacteria
Wang, T., Ahmad, S., Cruz-Lebrón, A., Ernst, S. E., Caicedo, K. Y. O., Jeong, Y., Binion, B., Mbuvi, P., Dutta, D., Fernández-Materán, F. V., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-01979-9 · Cited by 49
Polycystic ovary syndrome in adolescents
Dabadghao, P. (2019) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2019.04.006 · Cited by 48
Wang, Y., Ding, Y., Zhang, F., Zhang, R., Zhu, J., Wang, H., He, M., & Sun, Y. (2021) · Endocrinology · doi:10.1210/endocr/bqab258 · Cited by 38
Genetic Disruption of 21-Hydroxylase in Zebrafish Causes Interrenal Hyperplasia
Eachus, H., Zaucker, A., Oakes, J., Griffin, A., Weger, M., Güran, T., TAYLOR, A. E. R., Harris, A., Greenfield, A., Quanson, J. L., et al. (2017) · Endocrinology · doi:10.1210/en.2017-00549 · Cited by 33
Self-citationTurcu, A. F., El-Maouche, D., Zhao, L., Nanba, A. T., Gaynor, A., Veeraraghavan, P., Auchus, R. J., & Merke, D. P. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0129 · Cited by 33
du Toit, T., Stander, M. A., & Swart, A. C. (2018) · Journal of Chromatography B · doi:10.1016/j.jchromb.2018.02.023 · Cited by 31
Caron, P., Turcotte, V., & Guillemette, C. (2021) · Journal of Chromatography A · doi:10.1016/j.chroma.2021.462228 · Cited by 34
Barnard, L., du Toit, T., & Swart, A. C. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111189 · Cited by 33
Steroid Mass Spectrometry for the Diagnosis of PCOS
Keevil, B. G. (2019) · Medical Sciences · doi:10.3390/medsci7070078 · Cited by 36
du Toit, T., & Swart, A. C. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105497 · Cited by 32
Update on adrenal steroid hormone biosynthesis and clinical implications
Bacila, I. A., Elder, C. J., & Krone, N. P. (2019) · Archives of Disease in Childhood · doi:10.1136/archdischild-2017-313873 · Cited by 39
Hawley, J. M., Adaway, J., Owen, L. J., & Keevil, B. G. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-0959 · Cited by 31
Solorzano, C. M. B., & McCartney, C. R. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.10.003 · Cited by 39
Steroid reference intervals in women: influence of menopause, age and metabolism
Mezzullo, M., Gambineri, A., Dalmazi, G. D., Fazzini, A., Magagnoli, M., Baccini, M., Vicennati, V., Pelusi, C., Pagotto, U., & Fanelli, F. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1147 · Cited by 28
Idkowiak, J., Elhassan, Y., Mannion, P., Smith, K. A., Webster, R., Saraff, V., Barrett, T. G., Shaw, N. J., Krone, N. P., Dias, R. P., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0854 · Cited by 29
Self-citationBarnard, L., Schiffer, L., Louw du-Toit, R., Tamblyn, J. A., Chen, S., Africander, D., Arlt, W., Foster, P. A., & Storbeck, K.-H. (2021) · Endocrinology · doi:10.1210/endocr/bqaa231 · Cited by 27
Self-citationGrassi, G., Polledri, E., Fustinoni, S., Chiodini, I., Ceriotti, F., D’Agostino, S., Filippi, F., Somigliana, E., Mantovani, G., Arosio, M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm10010119 · Cited by 27
Ostinelli, G., Vijay, J., Vohl, M., Grundberg, E., & Tchernof, A. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111220 · Cited by 32
Tosi, F., Villani, M., Garofalo, S., Faccin, G., Bonora, E., Fiers, T., Kaufman, J., & Moghetti, P. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab920 · Cited by 31
The Unique Role of 11-Oxygenated C19 Steroids in Both Premature Adrenarche and Premature Pubarche
Wise-Oringer, B. K., Burghard, A. C., O’Day, P., Hassoun, A. A., Sopher, A. B., Fennoy, I., Williams, K. M., Vuguin, P. M., Nandakumar, R., McMahon, D. J., et al. (2020) · Hormone Research in Paediatrics · doi:10.1159/000513236 · Cited by 28
van Rooyen, D., Yadav, R., Scott, E. E., & Swart, A. C. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105614 · Cited by 27
Metadata
- Authors
- O’Reilly, M. W., Kempegowda, P., Jenkinson, C., Taylor, A. E., Quanson, J. L., Storbeck, K.-H., & Arlt, W.
- Affiliations
- University of Birmingham (GB)
- Stellenbosch University (ZA)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Corresponding author
- Arlt, Wiebke
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-11-30
- Volume
- 102
- Issue
- 3
- Pages
- 840-848
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC5460696
- OpenAlex
- W2557976244
- Cited by
- 267
- References
- 36
- Citations by year
- 2026: 26 · 2025: 28 · 2024: 24 · 2023: 23 · 2022: 29 · 2021: 38 · 2020: 36 · 2019: 29 · 2018: 25 · 2017: 8
- FWCI
- 27.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (099909, 092283)
- Newton Fund
- National Institute for Health and Care Research (ACF-2013-09-001)
- Royal Society
- Academy of Medical Sciences (NAF004\1002)
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- polycystic ovary syndrome, hyperandrogenism, hyperandrogenemia, 11β-hydroxyandrostenedione, 11-ketoandrostenedione, 11β-hydroxytestosterone, 11-ketotestosterone, androgen metabolism, insulin resistance, obesity, testosterone, androstenedione, dehydroepiandrosterone
- MeSH terms
- Adult, Androgens, Androstenedione, Androstenes, Blood Glucose, Chromatography, Liquid, Dehydroepiandrosterone, Female, Humans, Hydroxytestosterones, Insulin, Insulin Resistance, Gas Chromatography-Mass Spectrometry, Obesity, Polycystic Ovary Syndrome, Testosterone, Case-Control Studies, Hyperandrogenism, Tandem Mass Spectrometry, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.